Cite
LBH589, a deacetylase inhibitor, induces apoptosis in adult T-cell leukemia/lymphoma cells via activation of a novel RAIDD-caspase-2 pathway.
MLA
Hasegawa, H., et al. “LBH589, a Deacetylase Inhibitor, Induces Apoptosis in Adult T-Cell Leukemia/Lymphoma Cells via Activation of a Novel RAIDD-Caspase-2 Pathway.” Leukemia (08876924), vol. 25, no. 4, Apr. 2011, pp. 575–87. EBSCOhost, https://doi.org/10.1038/leu.2010.315.
APA
Hasegawa, H., Yamada, Y., Tsukasaki, K., Mori, N., Tsuruda, K., Sasaki, D., Usui, T., Osaka, A., Atogami, S., Ishikawa, C., Machijima, Y., Sawada, S., Hayashi, T., Miyazaki, Y., & Kamihira, S. (2011). LBH589, a deacetylase inhibitor, induces apoptosis in adult T-cell leukemia/lymphoma cells via activation of a novel RAIDD-caspase-2 pathway. Leukemia (08876924), 25(4), 575–587. https://doi.org/10.1038/leu.2010.315
Chicago
Hasegawa, H., Y. Yamada, K. Tsukasaki, N. Mori, K. Tsuruda, D. Sasaki, T. Usui, et al. 2011. “LBH589, a Deacetylase Inhibitor, Induces Apoptosis in Adult T-Cell Leukemia/Lymphoma Cells via Activation of a Novel RAIDD-Caspase-2 Pathway.” Leukemia (08876924) 25 (4): 575–87. doi:10.1038/leu.2010.315.